Allogene Therapeutics Inc
ALLO · NASDAQ1.94
1.94
USD0.000.09%Balance Sheet
Total Assets
717.8M
Liabilities And Stockholders Equity
717.8M
Income Statement
Total Revenue
-
Cost Of Revenue
5.03M
Gross Profit
-5.03M
Total Operating Expenses
202.01M
Operating Income
-202.01M
Income Before Tax
-184.93M
Net Income After Taxes
-184.59M
Net Income Before Extraordinary Items
-184.59M
Net Income
-184.59M
Net Income Applicable To Common Shares
-184.59M
Diluted Net Income
-184.59M
Diluted Weighted Average Shares
101
Diluted EPS Excluding Extraordinary Items
-1.83
Diluted Normalized EPS
-1.83
EBIT
-202.01M
Cash Flow
Total Cash From Operating Activities
-137.35M
Total Cash Flows From Investing Activities
164.08M
Total Cash From Financing Activities
58.96M
Exchange Rate Changes
-
Change In Cash
85.69M
Free Cash Flow
-188.14M
What are you waiting for?Start making profit today
©
2025
All rights reserved